{"id":792340,"date":"2024-12-04T08:33:05","date_gmt":"2024-12-04T13:33:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/"},"modified":"2024-12-04T08:33:05","modified_gmt":"2024-12-04T13:33:05","slug":"vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/","title":{"rendered":"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast<\/b><\/p>\n<p>ALAMEDA, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nVivani Medical, Inc. (NASDAQ: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fvani&amp;esheet=54158570&amp;newsitemid=20241204260216&amp;lan=en-US&amp;anchor=VANI&amp;index=1&amp;md5=444e99bbf0b6daa20386853c055ac45e\">VANI<\/a>) (the \u201cCompany\u201d or \u201cVivani\u201d), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present and participate in a panel discussion at the Innovation in Obesity Therapeutics Summit West Coast, taking place in San Diego, California, from December 10-12, 2024.<\/p>\n<p>\nEvent details are as follows:<\/p>\n<p><b>Panel Discussion: The Obesity Race on the Manufacturing Floor \u2013 Exploring Supply Challenges with Innovations in Discovery<br \/>\n<br \/><\/b>Panel Date: Wednesday, December 11, 2024<br \/>\n<br \/>Panel Time: 2:40 pm, Pacific Time<\/p>\n<p>\nDr. Mendelsohn will be joined by Feng Liu, Executive Director at Regor Therapeutics, and David Bearss, co-founder and Chairman at Biolexis Therapeutics, in a panel discussion of supply chain challenges for GLP-1 drugs and the innovative solutions that are being explored to address these issues.<\/p>\n<p><b>Presentation: Advancing Chronic Disease Management with Ultra Long-Acting Miniature Subdermal Implants of GLP-1<br \/>\n<br \/><\/b>Presentation Date: Wednesday, December 11, 2024<br \/>\n<br \/>Presentation Time: 4:20pm, Pacific Time<\/p>\n<p>\nIn this session, Dr. Mendelsohn will provide an overview of Vivani\u2019s emerging portfolio of miniature, drug implant candidates designed to revolutionize the treatment of chronic diseases by leveraging the company\u2019s proprietary NanoPortal\u2122 implant technology. The Company\u2019s lead program, NPM-119, is a six-month GLP-1 (exenatide) implant in development for chronic weight management. Clinical data from LIBERATE-1, the first-in-human, study in obese and overweight individuals, is expected in 2025. These ultra long-acting implants are designed for once or twice-yearly dosing and directly address main [major] challenges to optimal treatment, including poor medication adherence and potentially poor patient tolerability.<\/p>\n<p>\nMore information about Innovation in Obesity Therapeutics Summit West Coast can be found at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finnovation-obesity-summit.com%2F&amp;esheet=54158570&amp;newsitemid=20241204260216&amp;lan=en-US&amp;anchor=https%3A%2F%2Finnovation-obesity-summit.com%2F&amp;index=2&amp;md5=686024e23209c96910d702b55d9da429\">https:\/\/innovation-obesity-summit.com\/<\/a>.<\/p>\n<p><b>About Vivani Medical, Inc.<\/b><\/p>\n<p>\nLeveraging its proprietary NanoPortal\u2122 platform, Vivani develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Vivani\u2019s lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in obese or overweight individuals. Vivani\u2019s emerging pipeline also includes the NPM-139 (semaglutide implant) which is also under development for chronic weight management in obese and overweight individuals. The semaglutide implant has the added potential benefit of once-yearly administration. NPM-119 refers to the Company\u2019s type 2 diabetes development program utilizing a six-month, subdermal exenatide implant. Both the NPM-115 and NPM-119 programs utilize exenatide-based products with a higher-dose associated with the NPM-115 program for chronic weight management in obese or overweight patients. These NanoPortal\u2122 implants are designed to provide patients with the opportunity to realize the full potential benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables. Medication non-adherence occurs when patients do not take their medication as prescribed. This affects an alarming number of patients, approximately 50%, including those taking daily pills. Medication non-adherence, which contributes to more than $500 billion in annual avoidable healthcare costs and 125,000 potentially preventable deaths annually in the U.S. alone, is a primary and daunting reason obese or overweight patients, and patients taking type 2 diabetes or other chronic disease treatments face significant challenges in achieving positive real-world effectiveness. While the current GLP-1 landscape includes over 50 new molecular entities under clinical stage development, Vivani remains confident that its highly differentiated portfolio of miniature long-acting GLP-1 implants have the potential to provide an attractive therapeutic option for patients, prescribers and payers.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis press release contains certain \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: \u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cwill,\u201d \u201cmay,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cwould,\u201d \u201cpositioned,\u201d \u201cfuture,\u201d and other similar expressions that in this press release, including statements regarding Vivani\u2019s business, products in development, including the therapeutic potential thereof, the planned development therefor, the initiation of the LIBERATE-1 trial and reporting of trial results, Vivani\u2019s emerging development plans for NPM-115, NPM-139, or Vivani\u2019s plans with respect to Cortigent and its proposed initial public offering, technology, strategy, cash position and financial runway. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Vivani\u2019s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Vivani\u2019s control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, risks related to the development and commercialization of Vivani\u2019s products, including NPM-115 and NPM-119; delays and changes in the development of Vivani\u2019s products, including as a result of applicable laws, regulations and guidelines, potential delays in submitting and receiving regulatory clearance or approval to conduct Vivani\u2019s development activities, including Vivani\u2019s ability to commence clinical development of NPM-119; risks related to the initiation, enrollment and conduct of Vivani\u2019s planned clinical trials and the results therefrom; Vivani\u2019s history of losses and Vivani\u2019s ability to access additional capital or otherwise fund Vivani\u2019s business; market conditions and the ability of Cortigent to complete its initial public offering. There may be additional risks that the Company considers immaterial, or which are unknown. A further list and description of risks and uncertainties can be found in the Company\u2019s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission filed on March 26, 2024, as updated by the Company\u2019s subsequent Quarterly Reports on Form 10-Q. Any forward-looking statement made by Vivani in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of added information, future developments or otherwise, except as required by law.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20241204260216\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20241204260216\/en\/<\/a><\/span><\/p>\n<p>\nCompany Contact:<br \/>\n<br \/>Donald Dwyer<br \/>\n<br \/>Chief Business Officer<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:info@vivani.com\">info@vivani.com<br \/>\n<\/a><br \/>(415) 506-8462<\/p>\n<p>Investor Relations Contact:<br \/>\n<br \/>Jami Taylor<br \/>\n<br \/>Investor Relations Advisor<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@vivani.com\">investors@vivani.com<br \/>\n<\/a><br \/>(415) 506-8462<\/p>\n<p>Media Contact:<br \/>\n<br \/>Sean Leous<br \/>\n<br \/>ICR Healthcare<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Sean.Leous@westwicke.com\">Sean.Leous@westwicke.com<br \/>\n<\/a><br \/>(646) 866-4012<\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Health Research General Health Pharmaceutical Biometrics Health Technology Fitness &amp; Nutrition Science Biotechnology Other Science Health Diabetes<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20241204260216\/en\/2316616\/3\/vivani-medical-600.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211; Vivani Medical, Inc. (NASDAQ: VANI) (the \u201cCompany\u201d or \u201cVivani\u201d), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present and participate in a panel discussion at the Innovation in Obesity Therapeutics Summit West Coast, taking place in San Diego, California, from December 10-12, 2024. Event details are as follows: Panel Discussion: The Obesity Race on the Manufacturing Floor \u2013 Exploring Supply Challenges with Innovations in Discovery Panel Date: Wednesday, December 11, 2024 Panel Time: 2:40 pm, Pacific Time Dr. Mendelsohn will be joined by Feng Liu, Executive Director at Regor Therapeutics, and David Bearss, co-founder &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-792340","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211; Vivani Medical, Inc. (NASDAQ: VANI) (the \u201cCompany\u201d or \u201cVivani\u201d), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present and participate in a panel discussion at the Innovation in Obesity Therapeutics Summit West Coast, taking place in San Diego, California, from December 10-12, 2024. Event details are as follows: Panel Discussion: The Obesity Race on the Manufacturing Floor \u2013 Exploring Supply Challenges with Innovations in Discovery Panel Date: Wednesday, December 11, 2024 Panel Time: 2:40 pm, Pacific Time Dr. Mendelsohn will be joined by Feng Liu, Executive Director at Regor Therapeutics, and David Bearss, co-founder &hellip; Continue reading &quot;Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-04T13:33:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast\",\"datePublished\":\"2024-12-04T13:33:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/\"},\"wordCount\":1123,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/\",\"name\":\"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2024-12-04T13:33:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/","og_locale":"en_US","og_type":"article","og_title":"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Market Newsdesk","og_description":"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211; Vivani Medical, Inc. (NASDAQ: VANI) (the \u201cCompany\u201d or \u201cVivani\u201d), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present and participate in a panel discussion at the Innovation in Obesity Therapeutics Summit West Coast, taking place in San Diego, California, from December 10-12, 2024. Event details are as follows: Panel Discussion: The Obesity Race on the Manufacturing Floor \u2013 Exploring Supply Challenges with Innovations in Discovery Panel Date: Wednesday, December 11, 2024 Panel Time: 2:40 pm, Pacific Time Dr. Mendelsohn will be joined by Feng Liu, Executive Director at Regor Therapeutics, and David Bearss, co-founder &hellip; Continue reading \"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-04T13:33:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast","datePublished":"2024-12-04T13:33:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/"},"wordCount":1123,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/","name":"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2024-12-04T13:33:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204260216r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-present-at-the-innovation-in-obesity-therapeutics-summit-west-coast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=792340"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792340\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=792340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=792340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=792340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}